217 related articles for article (PubMed ID: 27174504)
41. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study.
Gonsalves GS; Crawford FW
Lancet HIV; 2018 Oct; 5(10):e569-e577. PubMed ID: 30220531
[TBL] [Abstract][Full Text] [Related]
42. Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa.
Coburn BJ; Okano JT; Blower S
Sci Transl Med; 2017 Mar; 9(383):. PubMed ID: 28356504
[TBL] [Abstract][Full Text] [Related]
43. Estimating HIV incidence, prevalence, and percent of undiagnosed infections in Taiwan using CD4 data.
Wu SB; Huang YC; Huang YF; Huang JC
J Formos Med Assoc; 2022 Feb; 121(2):482-489. PubMed ID: 34154894
[TBL] [Abstract][Full Text] [Related]
44. The changing epidemiology of HIV in 2013.
Beyrer C; Abdool Karim Q
Curr Opin HIV AIDS; 2013 Jul; 8(4):306-10. PubMed ID: 23743721
[TBL] [Abstract][Full Text] [Related]
45. Modelling the dynamics of population viral load measures under HIV treatment as prevention.
Rozhnova G; Anastasaki M; Kretzschmar M
Infect Dis Model; 2018; 3():160-170. PubMed ID: 30839936
[TBL] [Abstract][Full Text] [Related]
46. Changing risk behaviours and the HIV epidemic: a mathematical analysis in the context of treatment as prevention.
Ramadanovic B; Vasarhelyi K; Nadaf A; Wittenberg RW; Montaner JS; Wood E; Rutherford AR
PLoS One; 2013; 8(5):e62321. PubMed ID: 23671592
[TBL] [Abstract][Full Text] [Related]
47. Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort.
Le Guillou A; Cabie A; Delpierre C; Pugliese P; Jacomet C; Hentzien M; Duvivier C; Zaegel-Faucher O; Cotte L; Raffi F; Bani-Sadr F;
Public Health; 2021 Jul; 196():129-134. PubMed ID: 34192605
[TBL] [Abstract][Full Text] [Related]
48. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
Xu Y; Laeyendecker O; Wang R
Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
[TBL] [Abstract][Full Text] [Related]
49. Global HIV epidemiology: A guide for strategies in prevention and care.
Vermund SH
Curr HIV/AIDS Rep; 2014 Jun; 11(2):93-8. PubMed ID: 24691698
[TBL] [Abstract][Full Text] [Related]
50. Elimination of HIV transmission in Japanese MSM with combination interventions.
Wang Y; Tanuma J; Li J; Iwahashi K; Peng L; Chen C; Hao Y; Gilmour S
Lancet Reg Health West Pac; 2022 Jun; 23():100467. PubMed ID: 35602412
[TBL] [Abstract][Full Text] [Related]
51. Human Immunodeficiency Virus Epidemic Control in the United States: An Assessment of Proposed UNAIDS Metrics, 2010-2015.
Bosh KA; Brooks JT; Hall HI
Clin Infect Dis; 2019 Sep; 69(8):1431-1433. PubMed ID: 30805624
[TBL] [Abstract][Full Text] [Related]
52. Changing demographics in an HIV-infected population: results from an observational cohort study in Western Denmark.
Jensen-Fangel S; Pedersen C; Larsen CS; Tauris P; Møller A; Obel N
Scand J Infect Dis; 2001; 33(10):765-70. PubMed ID: 11728045
[TBL] [Abstract][Full Text] [Related]
53. Modeling of the HIV epidemic and continuum of care in French Guiana.
Nacher M; Adriouch L; Huber F; Vantilcke V; Djossou F; Elenga N; Adenis A; Couppié P
PLoS One; 2018; 13(5):e0197990. PubMed ID: 29795698
[TBL] [Abstract][Full Text] [Related]
54. HIV epidemic control-a model for optimal allocation of prevention and treatment resources.
Alistar SS; Long EF; Brandeau ML; Beck EJ
Health Care Manag Sci; 2014 Jun; 17(2):162-81. PubMed ID: 23793895
[TBL] [Abstract][Full Text] [Related]
55. Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark, Norway and Sweden.
Amundsen EJ; Stigum H; Røttingen JA; Aalen OO
Epidemiol Infect; 2004 Dec; 132(6):1139-49. PubMed ID: 15635973
[TBL] [Abstract][Full Text] [Related]
56. Responding to the global epidemic of amphetamine-type stimulant use compromising biomedical HIV prevention among men who have sex with men.
Carrico AW; Ewart LD; Davidovich U; Maher L; Jonas KJ; Horvath KJ; Hirshfield S; Guadamuz TE; Carney T; Grov C
Lancet HIV; 2024 Jun; 11(6):e350-e352. PubMed ID: 38816140
[No Abstract] [Full Text] [Related]
57. Prospects of elimination of HIV with test-and-treat strategy.
Kretzschmar ME; Schim van der Loeff MF; Birrell PJ; De Angelis D; Coutinho RA
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15538-43. PubMed ID: 24009342
[TBL] [Abstract][Full Text] [Related]
58. Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics.
Volz EM; Ndembi N; Nowak R; Kijak GH; Idoko J; Dakum P; Royal W; Baral S; Dybul M; Blattner WA; Charurat M
Virus Evol; 2017 Jul; 3(2):vex014. PubMed ID: 28775893
[TBL] [Abstract][Full Text] [Related]
59. Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013.
Nuñez O; Hernando V; Díaz A
AIDS; 2018 Nov; 32(17):2573-2581. PubMed ID: 30096075
[TBL] [Abstract][Full Text] [Related]
60. A multi-state Markov model using notification data to estimate HIV incidence, number of undiagnosed individuals living with HIV, and delay between infection and diagnosis: Illustration in France, 2008-2018.
Castel C; Sommen C; Strat YL; Alioum A
Stat Methods Med Res; 2021 Nov; 30(11):2382-2398. PubMed ID: 34606379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
